Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.4130
+0.0210 (5.36%)
Oct 7, 2025, 4:41 PM CET
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €26.88 million as of October 7, 2025. Its market cap has increased by 31.37% in one year.
Market Cap
26.88M
Enterprise Value
28.70M
Revenue
2.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.41
Market Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 26.88M, a decrease of -64.00%. That is a compound annual growth rate of -12.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 26.88M | 47.03% |
| Dec 31, 2024 | 18.28M | -20.03% |
| Dec 29, 2023 | 22.86M | 84.02% |
| Dec 30, 2022 | 12.42M | -40.67% |
| Dec 30, 2021 | 20.94M | -3.86% |
| Dec 31, 2020 | 21.78M | -72.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 7.51B |
| Laboratorios Farmaceuticos Rovi | 3.13B |
| Almirall | 2.56B |
| Pharma Mar | 1.61B |
| Faes Farma | 1.36B |
| Clínica Baviera | 667.40M |
| Laboratorio Reig Jofre | 259.64M |
| Oryzon Genomics | 255.88M |